PFM Health Sciences’s Acadia Healthcare ACHC Stock Holding History

PFM Health Sciences’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.6M	Buy	+582,745	New	+$10.5M	1.24%	25
2024 Q4	–	Sell	-686,150	Closed	-$43.5M	–	84
2024 Q3	$43.5M	Buy	686,150 +265,986	+63%	+$19.2M	2.47%	13
2024 Q2	$28.4M	Buy	420,164 +152,430	+57%	+$10.6M	1.4%	26
2024 Q1	$21.2M	Sell	267,734 -40,203	-13%	-$3.29M	1%	35
2023 Q4	$23.9M	Sell	307,937 -69,932	-19%	-$5.18M	1.44%	25
2023 Q3	$26.6M	Sell	377,869 -3,433	-0.9%	-$257K	1.25%	35
2023 Q2	$30.4M	Buy	381,302 +70,367	+23%	+$5.09M	1.18%	37
2023 Q1	$22.5M	Buy	+310,935	New	+$24.2M	0.99%	41
2016 Q2	–	Sell	-130,817	Closed	-$7.21M	–	80
2016 Q1	$7.21M	Buy	+130,817	New	+$7.47M	0.22%	72
2015 Q3	–	Sell	-227,174	Closed	-$17.8M	–	77
2015 Q2	$17.8M	Buy	+227,174	New	+$16.4M	0.45%	60

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PFM Health Sciences's ACHC Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Acadia Healthcare (ACHC) in Q1 2026: 582,745 shares worth $13.6M. The stake represents 1.24% of the portfolio and ranks #25 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in ACHC as recently as Q3 2024.

PFM Health Sciences first reported a position in ACHC in Q2 2015 and has held it in 10 quarters since. The position peaked at $43.5M in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

PFM Health Sciences held 582,745 shares of Acadia Healthcare worth $13.6M as of Q1 2026.
Acadia Healthcare was a new PFM Health Sciences position in Q1 2026.
Acadia Healthcare made up 1.24% of PFM Health Sciences's portfolio in Q1 2026, its #25 holding.
PFM Health Sciences first reported a position in Acadia Healthcare in Q2 2015 and has held it in 10 quarters since.
PFM Health Sciences's Acadia Healthcare position peaked at $43.5M in Q3 2024.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.